公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy | Liu, Ping-Yen; Su, Cheng-Huang; Kuo, Feng-Yu; Lee, Wen-Lieng; YI-CHIH WANG ; Lin, Wei-Shiang; Chu, Pao-Hsien; Lu, Tse-Min; Lo, Ping-Han; Lee, Cheng-Han; Lan, Wei-Ren; Huang, Chien-Lung; Tsukiyama, Shuji; Yang, Wei-Chen; Cheng, Li-Chung; Rafael, Virginia; Nikolajsen, Christian; Yin, Wei-Hsian | Cardiovascular intervention and therapeutics | 0 | 0 | |
2022 | Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study | Kuo, Feng-Yu; Lee, Cheng-Han; Lan, Wei-Ren; Su, Cheng-Huang; Lee, Wen-Lieng; YI-CHIH WANG ; Lin, Wei-Shiang; Chu, Pao-Hsien; Lu, Tse-Min; Lo, Ping-Han; Tsukiyama, Shuji; Yang, Wei-Chen; Cheng, Li-Chung; Huang, Chien-Lung; Yin, Wei-Hsian; Liu, Ping-Yen | Journal of the Formosan Medical Association = Taiwan yi zhi | 6 | 2 | |
2022 | A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study | Lee, Wen-Lieng; YI-CHIH WANG ; Su, Chieh-Shou; Lee, Hsin-Fu; Tung, Ying-Chang; Liu, Ping-Yen; Su, Cheng-Huang; Kuo, Feng-Yu; Lin, Wei-Shiang; Chu, Pao-Hsien; Lu, Tse-Min; Lo, Ping-Han; Tsukiyama, Shuji; Yang, Wei-Chen; Cheng, Li-Chung; Yin, Wei-Hsian; YEN-HUNG LIN | Acta Cardiologica Sinica | 1 | 1 | |
2022 | Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy | Liu, Ping-Yen; Su, Cheng-Huang; Kuo, Feng-Yu; Lee, Wen-Lieng; YI-CHIH WANG ; Lin, Wei-Shiang; Chu, Pao-Hsien; Lu, Tse-Min; Lo, Ping-Han; Lee, Cheng-Han; Lan, Wei-Ren; Huang, Chien-Lung; Tsukiyama, Shuji; Yang, Wei-Chen; Cheng, Li-Chung; Rafael, Virginia; Nikolajsen, Christian; Yin, Wei-Hsian | Cardiovascular intervention and therapeutics | 12 | 11 | |